Mexico · Delayed Price · Currency is MXN Atossa Therapeutics Statistics
Total Valuation
BMV:ATOS has a market cap or net worth of MXN 738.43 million. The enterprise value is -152.49 million.
| Market Cap | 738.43M |
| Enterprise Value | -152.49M |
Important Dates
The next estimated earnings date is Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 8.61M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +2.39% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 19.35% |
| Float | 8.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.81 |
| P/TBV Ratio | 0.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.28 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 0.32 |
Financial Position
The company has a current ratio of 6.77
| Current Ratio | 6.77 |
| Quick Ratio | 6.30 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -48.89% and return on invested capital (ROIC) is -33.26%.
| Return on Equity (ROE) | -48.89% |
| Return on Assets (ROA) | -29.87% |
| Return on Invested Capital (ROIC) | -33.26% |
| Return on Capital Employed (ROCE) | -65.99% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -36.90M |
| Employee Count | 15 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -67.79% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -67.79% |
| 50-Day Moving Average | 201.17 |
| 200-Day Moving Average | 272.08 |
| Relative Strength Index (RSI) | 20.88 |
| Average Volume (20 Days) | 101 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.98 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -602.65M |
| Pretax Income | -553.57M |
| Net Income | -553.57M |
| EBITDA | -602.36M |
| EBIT | -602.65M |
| Earnings Per Share (EPS) | -64.60 |
Balance Sheet
The company has 950.95 million in cash and n/a in debt, with a net cash position of 950.95 million.
| Cash & Cash Equivalents | 950.95M |
| Total Debt | n/a |
| Net Cash | 950.95M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 913.20M |
| Book Value Per Share | 106.05 |
| Working Capital | 870.39M |
Cash Flow
In the last 12 months, operating cash flow was -481.92 million and capital expenditures -293,475, giving a free cash flow of -482.22 million.
| Operating Cash Flow | -481.92M |
| Capital Expenditures | -293,475 |
| Free Cash Flow | -482.22M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BMV:ATOS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.39% |
| Shareholder Yield | -2.39% |
| Earnings Yield | -74.97% |
| FCF Yield | -65.30% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 2, 2026. It was a reverse split with a ratio of 0.0666666667.
| Last Split Date | Feb 2, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.0666666667 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |